How to Obtain Perfect Positioning for Renal Flow Scintigraphy Using 99mTc-MAG3

被引:1
|
作者
Deimer, Danielle
机构
关键词
D O I
10.2967/jnmt.123.266651
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Assessment of the kidney's vascular flow is a vital component of the renal scan; however, achieving perfect positioning for a Tc-99m-mercaptoacetyltriglycine (Tc-99m-MAG3) renal scan can be an uphill struggle, even with a recent CT scan to refer to. Typically, the kidneys are located bilaterally and posteriorly near the upper lumbar vertebrae, with the left kidney slightly more superior than the right (Fig. 1). The quick pace of renal arterial flow leaves little room to readjust positioning should the kidneys not be in the field of view (1). Typically, the aorta is visible within 1 s after injection, and the kidneys can be viewed within 5-6 s. Maximal kidney activity is usually seen within 30-60 s after injection. Thus, it is essential to have correct positioning from the start of the scan. Too often, technologists say, "As long as the kidneys are in the field of view, we are good." However, interpreting physicians favor having the kidneys and bladder in all images to assess image data accurately.
引用
收藏
页码:102 / 103
页数:2
相关论文
共 50 条
  • [31] 99mTc-MAG3 SPECT/CT in a case of urolithiasis
    Ochoa-Figueroa, M. A.
    Davidsson, A.
    Sanchez-Rodriguez, V.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (02): : 116 - 117
  • [32] Optimization of renal counting method for estimating 99mTc-MAG3 clearance.
    Zhao, C
    Shuke, N
    Okizaki, A
    Sato, J
    Ishikawa, Y
    Aburano, T
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 353P - 353P
  • [33] The reproducibility of measurements of differential renal function in paediatric 99mTc-MAG3 renography
    Brink, Anita
    Samal, Martin
    Mann, Michael D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (08) : 824 - 831
  • [34] Validation of alternative methods of preparing 99mTc-MAG3
    Seetharaman, Shankar
    Sosabowski, Michael H.
    Ballinger, James R.
    APPLIED RADIATION AND ISOTOPES, 2007, 65 (11) : 1240 - 1243
  • [35] Preparation and radiochemical purity control of 99mTc-MAG3
    Rebic, R.
    Beatovic, Slobodanka
    Obradovic, Vladimir
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S529 - S529
  • [36] Vesicocolic Fistula Detected by 99mTc-MAG3 Renogram
    Mannelli, Lorenzo
    Monti, Serena
    Bastawrous, Sarah
    Lomabardo, Ivano
    Behnia, Fatemeh
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (01) : 73 - 75
  • [37] Biokinetcs and Dosimetry of 99mTc-MAG3 scans in infants
    Machado, J. Soares
    Tran-Gia, J.
    Schloegl, S.
    Lassmann, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S398 - S399
  • [38] 99mTc-MAG3:: Review of pharmacokinetics, clinical application to renal diseases and quantification of renal function
    Itoh, K
    ANNALS OF NUCLEAR MEDICINE, 2001, 15 (03) : 179 - 190
  • [39] Laparoscopic versus laparotomic living donor nephrectomy: assessment of graft renal function by means of 99mTc-Mag3 dynamic renal scintigraphy
    Cecchin, D.
    Baldan, N.
    Furian, L.
    Ekser, B.
    Bodanza, V.
    Zucchetta, P.
    Marzola, M.
    Grassetto, G.
    Bui, F.
    Rigotti, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S229 - S229
  • [40] Investigation on labelling procedure and stability of 99mTc-mercaptoacetyltriglicine (99mTc-MAG3)
    Di Franco, M.
    Fantini, L.
    Trevisiol, E.
    Angusti, T.
    Giors, M.
    Micca, A. Botto
    Martino, M.
    Sacco, R.
    Podio, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S330 - S330